Bioadaptives, Inc.

BDPT Biotech & pharma

Develops dietary supplements for cognitive health and weight loss.

Jun 2026Revenue $25.6K/yrExpenses $935K/yr
No trend
Figures by year

When will Bioadaptives be profitable?

Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $25.6K and expenses $935K.

Fiscal year toRevenueExpensesOperating profit
Dec 2025$18.3K$1.06M−$1.04M
Dec 2024$12.7K$615K−$602K
Dec 2023$28.6K$257K−$229K
Dec 2022$17.2K$439K−$422K